Tellus Therapeutics

United States
Saint James, Maryland, United States, 27278

Company profile

Tellus Therapeutics company profile

Tellus Therapeutics is developing novel small molecules derived from human maternal breast milk for the treatment of newborns with perinatal brain injury. It was founded in 2018 and is based in Hillsborough, North Carolina.

Business identity

Phone number
919-491-4995
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Founded
2018-01-01, Year

Headquarters

Postal code
27278
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding rounds
8
Total equity funding
$53M
Last funding
Series Unknown / $16M / 2023-02-21
Last equity funding
Series Unknown / $16M
Investors
4
Lead investors
3
Founders
1
Articles
6

Founders and investors

Founders

Jason Kralic

Lead investors

North Carolina Biotechnology CenterOne North Carolina Small Business ProgramXontogeny

Investors

MassChallengeNorth Carolina Biotechnology CenterOne North Carolina Small Business ProgramXontogeny